{"id":"placebo-doxycycline","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"2-5%","effect":"Skin rash"},{"rate":"2-5%","effect":"Photosensitivity"},{"rate":"1-2%","effect":"Hypersensitivity reactions"}]},"_chembl":{"chemblId":"CHEMBL1256723","moleculeType":"Small molecule","molecularWeight":"480.90"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This inhibition prevents the formation of the 70S initiation complex, thereby blocking the translation of mRNA into proteins. As a result, bacteria are unable to synthesize essential proteins, leading to cell death. Doxycycline is effective against a wide range of bacteria, including those that cause respiratory tract infections, skin infections, and sexually transmitted diseases.","oneSentence":"Doxycycline is a broad-spectrum antibiotic that inhibits protein synthesis in bacteria by binding to the 30S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:49.853Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne"},{"name":"Chlamydia"},{"name":"Dermatological infections"},{"name":"Lyme disease"},{"name":"Mycoplasma pneumoniae infections"},{"name":"Plague"},{"name":"Rickettsial infections"},{"name":"Rosacea"},{"name":"Skin infections"},{"name":"Syphilis"}]},"trialDetails":[{"nctId":"NCT05840159","phase":"PHASE4","title":"A Study of Doxycycline to Treat Chlamydial Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-01-19","conditions":"Chlamydial Infection","enrollment":526},{"nctId":"NCT07488949","phase":"NA","title":"Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)","status":"RECRUITING","sponsor":"Fang Wang","startDate":"2024-04-09","conditions":"Chronic Endometritis","enrollment":1000},{"nctId":"NCT07485842","phase":"PHASE4","title":"FuKe Qianjin Capsule Plus Antibiotics for Chronic Endometritis","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University","startDate":"2026-04","conditions":"Chronic Endometritis","enrollment":300},{"nctId":"NCT01631617","phase":"PHASE2","title":"Effects of Treatments on Atopic Dermatitis","status":"RECRUITING","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","startDate":"2012-09-18","conditions":"Eczema, Dermatitis, Skin Diseases, Genetic","enrollment":130},{"nctId":"NCT05296837","phase":"PHASE4","title":"Ocular Rosacea Biome Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-06-22","conditions":"Ocular Rosacea, Antimicrobial Resistance","enrollment":50},{"nctId":"NCT05291468","phase":"NA","title":"the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2023-02-15","conditions":"Sarcoidosis, Pulmonary, Sarcoidosis Skin","enrollment":40},{"nctId":"NCT05382208","phase":"PHASE2","title":"Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-08-22","conditions":"Emphysema, HIV","enrollment":133},{"nctId":"NCT01917721","phase":"PHASE2","title":"Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hawaii Pacific Health","startDate":"2013-10","conditions":"Kawasaki Disease, Coronary Aneurysm","enrollment":50},{"nctId":"NCT03637400","phase":"PHASE2","title":"Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections Treatment","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2018-11-26","conditions":"Methicillin-resistant Staphylococcus Aureus, Skin Infection","enrollment":269},{"nctId":"NCT07230028","phase":"PHASE4","title":"Doxycycline Boosted Therapy in Lyme Borreliosis: DoBo Study.","status":"NOT_YET_RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2026-03-01","conditions":"Lyme Borreliosis, Nervous System","enrollment":50},{"nctId":"NCT05473520","phase":"PHASE3","title":"Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2023-05-24","conditions":"Tuberculosis, Acute Coronary Syndrome, Pulmonary Hypertension (Diagnosis)","enrollment":150},{"nctId":"NCT06446245","phase":"PHASE2","title":"Adjunctive Doxycycline for Central Nervous System Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-08-21","conditions":"Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology), Tuberculosis, Central Nervous System","enrollment":200},{"nctId":"NCT06477185","phase":"PHASE2","title":"Characterization of Tuberculosis Associated Lung Fibrosis and Respiratory Impairment, and Prevention Using Doxycycline","status":"RECRUITING","sponsor":"Makerere University","startDate":"2024-12-04","conditions":"Tuberculosis, Pulmonary","enrollment":200},{"nctId":"NCT03397004","phase":"PHASE2","title":"Doxycycline for Hereditary Hemorrhagic Telangiectasia","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2018-09-12","conditions":"Hereditary Hemorrhagic Telangiectasia (HHT)","enrollment":13},{"nctId":"NCT02864550","phase":"PHASE4","title":"Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex with Men (DaDHS)","status":"COMPLETED","sponsor":"British Columbia Centre for Disease Control","startDate":"2019-08-15","conditions":"Syphilis, Sexually Transmitted Infections","enrollment":52},{"nctId":"NCT03508232","phase":"PHASE2","title":"Doxycycline to Protect Heart Muscle After Heart Attacks","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2020-01-06","conditions":"ST Segment Elevation Myocardial Infarction, Heart Failure","enrollment":170},{"nctId":"NCT06693362","phase":"PHASE1","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-20","conditions":"Severe Viral Pneumonia(Not Include COVID-19)","enrollment":60},{"nctId":"NCT04846335","phase":"PHASE2","title":"Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2011-04-28","conditions":"Familial Fatal Insomnia","enrollment":29},{"nctId":"NCT05343455","phase":"PHASE3","title":"A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2)","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2022-03-29","conditions":"Papulopustular Rosacea","enrollment":330},{"nctId":"NCT05296629","phase":"PHASE3","title":"A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.","status":"COMPLETED","sponsor":"Journey Medical Corporation","startDate":"2022-03-14","conditions":"Papulopustular Rosacea","enrollment":323},{"nctId":"NCT04482686","phase":"PHASE1","title":"Trial of Combination Therapy to Treat COVID-19 Infection","status":"COMPLETED","sponsor":"ProgenaBiome","startDate":"2020-12-09","conditions":"COVID, Covid-19, Corona Virus Infection","enrollment":31},{"nctId":"NCT02553473","phase":"PHASE3","title":"Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis","status":"COMPLETED","sponsor":"Sorlandet Hospital HF","startDate":"2015-10","conditions":"Neuroborreliosis, Borrelia Burgdorferi","enrollment":121},{"nctId":"NCT00007735","phase":"PHASE3","title":"Antibiotic Treatment of Gulf War Veterans' Illnesses","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"1999-01","conditions":"Persian Gulf Syndrome, Mycoplasma Infections","enrollment":450},{"nctId":"NCT04649502","phase":"PHASE3","title":"Metformin for the Treatment of Hidradenitis Suppurativa (HS)","status":"COMPLETED","sponsor":"K.R. van Straalen","startDate":"2021-01-25","conditions":"Hidradenitis Suppurativa","enrollment":62},{"nctId":"NCT00066027","phase":"PHASE3","title":"Effects of Low-Dose Doxycycline on Oral Bone Loss","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2002-06-01","conditions":"Periodontitis","enrollment":128},{"nctId":"NCT05827211","phase":"NA","title":"The Usefulness of Antibiotics in Smokers Receiving Dental Implants","status":"COMPLETED","sponsor":"Arab American University (Palestine)","startDate":"2023-04-02","conditions":"Dental Implant Therapy","enrollment":80},{"nctId":"NCT03334682","phase":"PHASE3","title":"Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2018-01-31","conditions":"Acne Vulgaris","enrollment":158},{"nctId":"NCT04504123","phase":"PHASE2","title":"MMP-9 Inhibition for Recalcitrant Wet AMD","status":"UNKNOWN","sponsor":"University of Iowa","startDate":"2020-11-04","conditions":"Exudative Macular Degeneration, Wet Age-related Macular Degeneration","enrollment":50},{"nctId":"NCT01782989","phase":"PHASE2, PHASE3","title":"Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)","status":"COMPLETED","sponsor":"Paul Yates, MD, PhD","startDate":"2013-02","conditions":"Geographic Atrophy","enrollment":286},{"nctId":"NCT05492019","phase":"PHASE2","title":"Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients","status":"UNKNOWN","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2022-07-01","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT01426269","phase":"PHASE4","title":"Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-09","conditions":"Rosacea","enrollment":235},{"nctId":"NCT01308619","phase":"PHASE4","title":"Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-04","conditions":"Rosacea","enrollment":170},{"nctId":"NCT01744093","phase":"NA","title":"Doxycycline for COPD in HIV-Infected Patients","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2014-12-08","conditions":"HIV, Chronic Obstructive Pulmonary Disease (COPD), Emphysema","enrollment":61},{"nctId":"NCT04167085","phase":"PHASE4","title":"NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-12-18","conditions":"Epistaxis","enrollment":26},{"nctId":"NCT05398055","phase":"PHASE3","title":"Efficacy of Azithromycin Plus Doxycycline Versus Doxycycline Plus Placebo in Patients With Rocky Mountain Spotted Fever","status":"UNKNOWN","sponsor":"Hospital General de Mexicali","startDate":"2022-05-12","conditions":"Rocky Mountain Spotted Fever","enrollment":86},{"nctId":"NCT04451330","phase":"PHASE4","title":"A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2020-07-29","conditions":"Acne Vulgaris","enrollment":202},{"nctId":"NCT04371952","phase":"PHASE3","title":"DYNAMIC Study (DoxycYcliNe AMbulatoIre COVID-19)","status":"WITHDRAWN","sponsor":"Nantes University Hospital","startDate":"2021-02-01","conditions":"COVID19","enrollment":""},{"nctId":"NCT05040334","phase":"PHASE4","title":"Role of Prophylactic Antibiotics in Preventing Pelvic Infection After Surgical Evacuation","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-01-01","conditions":"Antibiotics Causing Adverse Effects in Therapeutic Use","enrollment":138},{"nctId":"NCT02756403","phase":"NA","title":"A Randomized Controlled Trial of Three Antibiotic Regimens for First Trimester Abortions","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2016-03","conditions":"First Trimester Abortion","enrollment":181},{"nctId":"NCT01756833","phase":"PHASE2","title":"Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2013-05","conditions":"Aneurysm","enrollment":261},{"nctId":"NCT04584567","phase":"PHASE3","title":"OD-doxy-PNV-COVID-19 Old Drug \" DOXY \" for Prevention of New Virus \" COVID-19 \"","status":"COMPLETED","sponsor":"Hedi Gharsallah","startDate":"2020-11-20","conditions":"Covid19","enrollment":194},{"nctId":"NCT02203682","phase":"PHASE2","title":"Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2014-07","conditions":"Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy","enrollment":100},{"nctId":"NCT03968562","phase":"PHASE2","title":"Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline","status":"UNKNOWN","sponsor":"State University of New York - Downstate Medical Center","startDate":"2019-05-15","conditions":"Hives","enrollment":25},{"nctId":"NCT03618108","phase":"PHASE2","title":"Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease","status":"TERMINATED","sponsor":"Cadrock Pty. Ltd.","startDate":"2018-04-04","conditions":"Coronary Heart Disease, Chlamydophila Pneumoniae Infections","enrollment":20},{"nctId":"NCT02929121","phase":"PHASE3","title":"A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in India","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2019-01-15","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":235},{"nctId":"NCT02927496","phase":"PHASE3","title":"A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2018-06-19","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":220},{"nctId":"NCT01318356","phase":"PHASE4","title":"The Qure Study: Q-fever Fatigue Syndrome - Response to Treatment","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2011-04","conditions":"Q Fever, Fatigue Syndrome, Chronic, Coxiella Infection","enrollment":156},{"nctId":"NCT01345526","phase":"PHASE2","title":"Efficacy and Safety of the Prophylactic Use of Doxycycline +/- Vitamin K Cream","status":"COMPLETED","sponsor":"Universitätsmedizin Mannheim","startDate":"2011-04","conditions":"Metastatic Colorectal Cancer","enrollment":124},{"nctId":"NCT04433078","phase":"PHASE2","title":"RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM","status":"WITHDRAWN","sponsor":"Temple University","startDate":"2020-06-22","conditions":"Cytokine Storm, SARS-CoV-2","enrollment":""},{"nctId":"NCT04729140","phase":"PHASE4","title":"An Outpatient Clinical Trial Using Ivermectin and Doxycycline in COVID-19 Positive Patients at High Risk to Prevent COVID-19 Related Hospitalization","status":"UNKNOWN","sponsor":"Max Health, Subsero Health","startDate":"2020-12-28","conditions":"Covid19","enrollment":150},{"nctId":"NCT04150250","phase":"PHASE2","title":"Cholera Anti-Secretory Treatment Trial","status":"COMPLETED","sponsor":"PATH","startDate":"2019-11-04","conditions":"Cholera","enrollment":47},{"nctId":"NCT02929134","phase":"PHASE3","title":"A 24 Month Study to Compare Efficacy of Doxycycline vs Placebo for Improving Filarial Lymphedema in Sri Lanka","status":"COMPLETED","sponsor":"The Task Force for Global Health","startDate":"2018-02-16","conditions":"Lymphedema, Lymphatic Filariasis, Filariasis","enrollment":219},{"nctId":"NCT03075891","phase":"PHASE4","title":"Oracea Soolantra Association in Participants With Severe Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2017-07-05","conditions":"Rosacea","enrollment":273},{"nctId":"NCT03340961","phase":"PHASE2","title":"A Controlled Study to Assess the Efficacy, Safety and Tolerability of Oral DFD-29 Extended Release Capsules","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2017-10-01","conditions":"Rosacea","enrollment":205},{"nctId":"NCT00560703","phase":"PHASE2","title":"Treatment of Patients With Blepharitis and Facial Rosacea","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2007-11","conditions":"Blepharitis, Meibomianitis, Dry Eye","enrollment":70},{"nctId":"NCT01320033","phase":"PHASE2","title":"Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris","status":"COMPLETED","sponsor":"Galderma R&D","startDate":"2011-03-29","conditions":"Acne Vulgaris","enrollment":662},{"nctId":"NCT04239755","phase":"PHASE4","title":"Doxycycline in Acute Traumatic Brain Injury","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2020-02-01","conditions":"Traumatic Brain Injury","enrollment":50},{"nctId":"NCT02606032","phase":"PHASE2","title":"Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2016-05","conditions":"Ulcerative Colitis","enrollment":75},{"nctId":"NCT04407130","phase":"PHASE2","title":"Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2020-06-16","conditions":"COVID-19 Patients","enrollment":72},{"nctId":"NCT01658995","phase":"PHASE3","title":"Management of Etonogestrel Subdermal Implant-related Bleeding","status":"COMPLETED","sponsor":"Petra M. Casey","startDate":"2012-09-13","conditions":"ESI-related Bleeding","enrollment":82},{"nctId":"NCT03608774","phase":"PHASE4","title":"Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-13","conditions":"Anal Chlamydia Infection","enrollment":177},{"nctId":"NCT04523831","phase":"PHASE3","title":"Clinical Trial of Ivermectin Plus Doxycycline for the Treatment of Confirmed Covid-19 Infection","status":"COMPLETED","sponsor":"Dhaka Medical College","startDate":"2020-06-01","conditions":"Covid19","enrollment":400},{"nctId":"NCT01411202","phase":"PHASE2","title":"Effectiveness of Doxycycline for Treating Pleural Effusions Related to Cancer in an Outpatient Population","status":"UNKNOWN","sponsor":"Ottawa Hospital Research Institute","startDate":"2011-06","conditions":"Malignant Pleural Effusion","enrollment":40},{"nctId":"NCT04551755","phase":"PHASE2","title":"Safety and Efficacy of Ivermectin and Doxycycline in Treatment of Covid-19","status":"UNKNOWN","sponsor":"Bangladesh Medical Research Council (BMRC)","startDate":"2020-09","conditions":"Covid19","enrollment":188},{"nctId":"NCT02456662","phase":"NA","title":"Scheduled Prophylactic Antiemetics for Reduction of Emesis With Doxycycline (SPARED) Trial","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2015-10-07","conditions":"Drug-induced Nausea and Vomiting","enrollment":319},{"nctId":"NCT02753426","phase":"PHASE1","title":"A Trial of Doxycycline in Renal Disease","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2016-04","conditions":"Chronic Kidney Disease, Cardiorenal Syndrome","enrollment":11},{"nctId":"NCT01375491","phase":"PHASE4","title":"Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2009-10","conditions":"Type 2 Diabetes, Obesity","enrollment":39},{"nctId":"NCT01867294","phase":"PHASE2","title":"Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab","status":"COMPLETED","sponsor":"Academic and Community Cancer Research United","startDate":"2012-08-31","conditions":"Advanced Malignant Neoplasm, Dermatologic Complication","enrollment":19},{"nctId":"NCT03960411","phase":"PHASE3","title":"Effect of Doxycycline on Cardiac Remodelling in STEMI Patients","status":"UNKNOWN","sponsor":"Felix Chikita Fredy, MD","startDate":"2019-05-25","conditions":"ST Elevation Myocardial Infarction, Anterior Wall Myocardial Infarction, Heart Failure","enrollment":80},{"nctId":"NCT02735837","phase":"PHASE2, PHASE3","title":"The Effect of Topical Doxycycline Gel on HbA1c in Patients With Type 2 Diabetes Mellitus(DM) ®","status":"COMPLETED","sponsor":"Amirhossein Farahmand","startDate":"2015-01","conditions":"Diabetes Mellitus With Periodontal Disease","enrollment":24},{"nctId":"NCT00322465","phase":"PHASE2","title":"NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-11","conditions":"Urethritis","enrollment":305},{"nctId":"NCT01594827","phase":"PHASE2","title":"Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-10","conditions":"Cystic Fibrosis","enrollment":29},{"nctId":"NCT01465802","phase":"PHASE2","title":"Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-12-26","conditions":"Non Small Cell Lung Cancer (NSCLC)","enrollment":236},{"nctId":"NCT00917553","phase":"PHASE2","title":"Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy","status":"COMPLETED","sponsor":"Thomas Gardner","startDate":"2009-07","conditions":"Diabetic Retinopathy","enrollment":33},{"nctId":"NCT00351273","phase":"PHASE3","title":"Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria","status":"COMPLETED","sponsor":"University of South Florida","startDate":"2006-05","conditions":"Arthritis, Reactive, Reiter Disease","enrollment":42},{"nctId":"NCT00511875","phase":"PHASE2","title":"Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy","status":"COMPLETED","sponsor":"Thomas Gardner","startDate":"2008-07","conditions":"Diabetic Retinopathy","enrollment":30},{"nctId":"NCT02726646","phase":"PHASE2","title":"Evaluation of Local Doxycycline in Smokers With Chronic Periodontitis","status":"COMPLETED","sponsor":"University of Campinas, Brazil","startDate":"2015-06","conditions":"Chronic Periodontitis","enrollment":40},{"nctId":"NCT01798225","phase":"PHASE4","title":"Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2007-12","conditions":"Periodontal Disease, Type 2 Diabetes Mellitus","enrollment":113},{"nctId":"NCT00358462","phase":"PHASE3","title":"Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2007-01","conditions":"Urethritis","enrollment":606},{"nctId":"NCT01160640","phase":"PHASE2","title":"The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)","status":"COMPLETED","sponsor":"Harold Wiesenfeld","startDate":"2010-11","conditions":"Pelvic Inflammatory Disease","enrollment":233},{"nctId":"NCT01198912","phase":"PHASE2","title":"Influence of Oral Doxycycline on Wound Healing After Endonasal Endoscopic Sinus Surgery for Chronic Rhinosinusitis With and Without Nasal Polyposis: a Double-blind Randomized Placebo-controlled Trial","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2011-11-22","conditions":"Chronic Rhinosinusitis, Nasal Polyps","enrollment":33},{"nctId":"NCT02913118","phase":"PHASE4","title":"Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia","status":"UNKNOWN","sponsor":"Qingfeng Pharmaceutical Group","startDate":"2016-07","conditions":"Community Acquired Pneumonia","enrollment":462},{"nctId":"NCT00439166","phase":"PHASE3","title":"Effects of Doxycycline and Rifampicin on Biomarkers of Alzheimer's Disease in the Cerebrospinal Fluid","status":"COMPLETED","sponsor":"Hamilton Health Sciences Corporation","startDate":"2007-02","conditions":"Alzheimer's Disease","enrollment":100},{"nctId":"NCT02239731","phase":"PHASE2","title":"Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients","status":"COMPLETED","sponsor":"Vyne Therapeutics Inc.","startDate":"2014-10","conditions":"Rash Due to Epidermal Growth Factor Receptor Inhibitors","enrollment":24},{"nctId":"NCT02569437","phase":"PHASE2","title":"Doxycycline in Treating Patients With Chronic Rhinosinusitis With Nasal Polyps","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2014-09","conditions":"Polyp of Nasal Sinus","enrollment":49},{"nctId":"NCT00246740","phase":"PHASE2","title":"Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2005-10","conditions":"Coronary Artery Bypass Grafting, Cardiopulmonary Bypass, Reperfusion Injury","enrollment":56},{"nctId":"NCT02774993","phase":"PHASE2","title":"Doxycycline in Human Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"National University Hospital, Singapore","startDate":"2015-09","conditions":"Tuberculosis","enrollment":40},{"nctId":"NCT02305940","phase":"PHASE3","title":"Effects of Long Term Antibiotic Therapy on Exacerbation Rate in Stable COPD Patients","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2014-07","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":222},{"nctId":"NCT00016835","phase":"PHASE2","title":"Treating Periodontal Infection: Effects on Glycemic","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2001-10-17","conditions":"Periodontal Disease, Diabetes Mellitus, Type 2","enrollment":46},{"nctId":"NCT00910715","phase":"NA","title":"Duration of Antibiotic Treatment of Erythema Migrans","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2009-06","conditions":"Erythema Chronicum Migrans","enrollment":306},{"nctId":"NCT00764361","phase":"PHASE2","title":"Safety Study of Topical Doxycycline Gel for Adult Diabetic Lower Extremity Ulcers","status":"COMPLETED","sponsor":"NanoSHIFT LLC","startDate":"2009-01","conditions":"Diabetic Foot Ulcer","enrollment":15},{"nctId":"NCT01547325","phase":"NA","title":"Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds","status":"WITHDRAWN","sponsor":"NanoSHIFT LLC","startDate":"2012-05","conditions":"Dehisced Surgical Wounds","enrollment":""},{"nctId":"NCT01112059","phase":"NA","title":"Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2008-11","conditions":"Cystic Fibrosis","enrollment":40},{"nctId":"NCT02850913","phase":"PHASE2","title":"Doxycycline for the Treatment of Nodding Syndrome","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2016-09-05","conditions":"Seizures","enrollment":230},{"nctId":"NCT01030666","phase":"PHASE4","title":"Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy","status":"TERMINATED","sponsor":"Peter Eickholz","startDate":"2007-04","conditions":"Periodontitis","enrollment":61},{"nctId":"NCT02845024","phase":"NA","title":"The Effect of Non-surgical Periodontal Therapy Plus Doxycycline on HbA1c in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Islamic Azad University, Sanandaj","startDate":"2014-09","conditions":"Diabetes Mellitus With Periodontal Disease","enrollment":24},{"nctId":"NCT01207739","phase":"PHASE4","title":"Persistent Lyme Empiric Antibiotic Study Europe","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2010-09","conditions":"Lyme Disease, Borrelia Infection","enrollment":280},{"nctId":"NCT02538224","phase":"PHASE2, PHASE3","title":"Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal Treatment","status":"COMPLETED","sponsor":"Islamic Azad University, Sanandaj","startDate":"2013-07","conditions":"Chronic Periodontitis","enrollment":20},{"nctId":"NCT02388477","phase":"NA","title":"Trial of the Use of Doxycycline After Rotator Cuff Repair","status":"WITHDRAWN","sponsor":"Milton S. Hershey Medical Center","startDate":"","conditions":"Rotator Cuff Injury","enrollment":""},{"nctId":"NCT02680275","phase":"NA","title":"Efficacy of Dead Sea Peloid Gel in Chronic Endometritis","status":"COMPLETED","sponsor":"Scientific Center for Family Health and Human Reproduction Problems, Russia","startDate":"2011-07","conditions":"Chronic Endometritis","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["B"],"phase":"phase_3","status":"active","brandName":"Placebo + Doxycycline","genericName":"Placebo + Doxycycline","companyName":"Hospital General de Mexicali","companyId":"hospital-general-de-mexicali","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Doxycycline is a small molecule used in clinical trials for various conditions, including Lateral Epicondylalgia (Tennis Elbow), Cystic Fibrosis, Aneurysm, Acne Vulgaris, and Ocular Rosacea. Placebo is also being studied in clinical trials for these conditions, often in comparison to Doxycycline.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}